CBFB (5D4) Monoclonal Antibody
Applications
Reactivity
Overview | |
Catalog # | bsm-54418R |
Product Name | CBFB (5D4) Monoclonal Antibody |
Applications | WB, FCM, IHC-P |
Reactivity | Human, Rat |
Specifications | |
Conjugation | Unconjugated |
Host | Rabbit |
Source | Recombinant protein within human CBFb aa 1-200. |
Clonality | Monoclonal |
Clone # | 5D4 |
Isotype | IgG |
Concentration | 1ug/ul |
Purification | Purified by Protein A. |
Storage Buffer | Aqueous buffered solution containing 1xTBS (pH7.4), 1%BSA, 40%Glycerol and 0.05% Sodium Azide. |
Storage Condition | Store at -20°C for 12 months. |
Target | |
Gene ID | 865 |
Swiss Prot | Q13951 |
Subcellular location | Nucleus |
Synonyms | Core-binding factor subunit beta; Polyomavirus enhancer-binding protein 2 beta subunit; SL3-3 enhancer factor 1 subunit beta; SL3/AKV core-binding factor beta subunit; CBF-beta; PEA2-beta; PEBP2-beta; CBFB |
Background | Forms the heterodimeric complex core-binding factor (CBF) with RUNX family proteins (RUNX1, RUNX2, and RUNX3). RUNX members modulate the transcription of their target genes through recognizing the core consensus binding sequence 5'-TGTGGT-3', or very rarely, 5'-TGCGGT-3', within their regulatory regions via their runt domain, while CBFB is a non-DNA-binding regulatory subunit that allosterically enhances the sequence-specific DNA-binding capacity of RUNX. The heterodimers bind to the core site of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL3 and GM-CSF promoters. CBF complexes repress ZBTB7B transcription factor during cytotoxic (CD8+) T cell development. They bind to RUNX-binding sequence within the ZBTB7B locus acting as transcriptional silencer and allowing for cytotoxic T cell differentiation. |
Application Dilution | |
WB | 1:300-5000 |
FCM | 1:20-100 |
IHC-P | 1:200-400 |